Related Articles
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines
Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican‑3‑derived peptide
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
Immunological evaluation of vaccination of peptides derived from epithelial cancer-related antigens in two patients with hematological malignancy
The anti-tumor immune response induced by a combination of MAGE-3/MAGE-n-derived peptides